Shengbang Wang

Statistics

Publications

Citations

H-Index

Active since

2017

Affiliations

Second Affiliated Hospital of Xi'an Jiaotong University(Current)

Xi'an Jiaotong University

Shengbang Wang is an author at Second Affiliated Hospital of Xi'an Jiaotong University specializing in oncology, antiviral therapy, and antiviral therapy in cirrhosis.

ORCID

Publications per year

2017–2024

Publications

LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways

Yingjian Huang, Yuqian Wang, Yan Wang et al. · Journal of Investigative Dermatology · 2021 · 32 citations

Medicine, Cancer Biology, Oncology +10

Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study

Fanpu Ji, Wenjun Wang, Shuangsuo Dang et al. · Infectious Agents and Cancer · 2017 · 17 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Identification of potential crucial genes shared in psoriasis and ulcerative colitis by machine learning and integrated bioinformatics

J. Zhang, Shuo Feng, Minfei Chen et al. · Skin Research and Technology · 2024 · 15 citations · Full text

Life Sciences, Bioinformatics, Immunology +17

High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy

Fanpu Ji, Rui Zhou, Wenjun Wang et al. · Journal of Interferon & Cytokine Research · 2017 · 14 citations

Medicine, Infectious Diseases, Oncology +17

1–4 of 4